Copyright
©The Author(s) 2019.
World J Stem Cells. Nov 26, 2019; 11(11): 1005-1019
Published online Nov 26, 2019. doi: 10.4252/wjsc.v11.i11.1005
Published online Nov 26, 2019. doi: 10.4252/wjsc.v11.i11.1005
Ref. | Purpose | Number of samples | Vol. of milk collected | Income cellcells/ mL | Markers - FC | Markers - IF | PCR | WB | Differentiation cell | Conclusion |
Patki et al[12] | To study the multipotent differentiation capacity of the long-term MSC culture. | 35 | 15 mL | 2.5 x 106-3.0 x 106/mL | CD29, CD33, CD34, CD44, CD45, CD73, SCA-1. | Nestin, Vimentin, Smooth Muscle Actin and E-Cadherin. | Not done | Not done | Adipogenic, chondroge-nic, osteogenic lineages. | Mesenchy-mal stem cells isolated from human breast milk have cellular potency to differentiate into different cell types. |
Hassiotou et al[13] | To examine regulators of self-renewal of hBSCs and their plasticity and potential to differentiate into cell types outside the mammary lineage. | > 70 | 5-200 mL | Not done | SSEA-4 e TRA-1-60 / TRA-1-81. | OCT4, SOX2 and Nanog. | TRA-1-60 / TRA-1-81, Oct4, Sox2, Klf4 and Nanog genes. | Oct4, Sox2 and Nanog. | Osteogenic, adipogenic, chondroge-nic, neuronal, pancreatic, hepatocyte, cardiomyo-cytes, mammary differentiation and teratoma. | Stem cells in breast milk contain pluripotency properties. |
Hosseini et al[14] | To differentiate the breast milk-derived stem cells toward neural stem cells and then into the neurons and neuroglia. | Not present | 5-200 mL | 4.0 x 104/mL | Not done | Nestin, Nanog, β-tubulin III, O4, GFAP, Oct4, Sox2, CD44, CD105, CD106, CD133. | Not done | Not done | Neurosphe-res, neurons, oligodendro-cytes, and astrocytes. | The breast milk-derived stem cells showed the capability to be differentia-ted into neural cell lineages and their similarity to both embryonic and mesenchy-mal stem cells makes them a good candidate for cell therapy in neurodegenerative diseases. |
Sani et al[15] | To examine the pluripotency of the human breast milk-derived cells. | 5 | 5-50 mL | Not done | CD90 CD44, CD144, CD 271, CD123, CD133, CD73, CD 106, CD146, CD45, CD 105,CD34, SSEA-4, TRA-60–1, CD 15/SSEA-1. | Oct4, Sox2, Nanog and CK18. | SRY gene | Not done | Osteogenic and adipogenic lineages. | Most of the cells found are mesenchy-mal stem cells, but, cells similar to embryonic stem cells are also present. |
Sani et al[16] | To examine the differentiation potential of the hBSCs into functional hepatocytes in vitro. | 15 | 5-50 mL | Not done | Not done | CK18, CK19, albumin, alpha-fetoprotein. | AFP, CK19, CYP2B6, HNF4, G6P. | Not done | Hepatocyte lineage. | The hBSCs demonstrate the ability to express many key factors that are important in liver functions. |
- Citation: Pacheco CMR, Ferreira PE, Saçaki CS, Tannous LA, Zotarelli-Filho IJ, Guarita-Souza LC, de Carvalho KAT. In vitro differentiation capacity of human breastmilk stem cells: A systematic review. World J Stem Cells 2019; 11(11): 1005-1019
- URL: https://www.wjgnet.com/1948-0210/full/v11/i11/1005.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v11.i11.1005